KALA KALA BIO, Inc.: Prakiraan wutah bathi resik saben saham kanggo taun ngarep

Lambang korporat lan logo kalarx.com (KALA)

KALA BIO, Inc. (KALA) is developing a portfolio of biologics to combat severe vision pathologies, mitigating regulatory risks through the diversification of testing stages. The one-year forward EPS growth rate visualizes these expectations, while 0.00 captures the magnitude of this parameter. KALA BIO, Inc. (KALA) utilizes a unique mucosal drug delivery method and is also implementing a stem cell platform for the subsequent licensing of products to industry behemoths.

KALA: Prakiraan wutah bathi kanggo taun ngarep Kala Pharmaceuticals 04.07.2022 - 17.11.2026

Rincian analitis lan laporan data perusahaan KALA BIO, Inc. (KALA)

- rega lan prakiraan konsensus rega:
- data kapitalisasi saham perusahaan:
Pambiji fundamental perusahaan:KALA BIO, KALA
Produk dadi Kala Pharmaceuticals

This indicator reflects the analysts' consensus forecast for the earnings per share growth rate for the coming year. An increase in this metric signals an expansion of the business's fundamental value and market confidence in future cash flows. By analyzing the expected EPS growth for the next year, an investor assesses the potential for profit scaling. For KALA BIO, Inc. (KALA), this is directly linked to the monetization of its unique ocular drug delivery technology.

Pesaing wigati

ALC (Alcon Corp) - Prakiraan wutah bathi kanggo taun ngarep|Bausch + Lomb Corporation (BLCO) - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep GKOS|Prakiraan wutah bathi kanggo taun ngarep Apellis Pharmaceuticals, Inc. (APLS)|Prakiraan wutah bathi kanggo taun ngarep BLTE (Belite Bio)|OCUL - Prakiraan wutah bathi saben saham kanggo taun ngarep|HROW - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Dinamika bathi saben saham sing diarepake ing taun ngarep VRDN (Viridian Therapeutics)|LENZ (LENZ Therapeutics, Inc.) - Prakiraan wutah bathi saben saham kanggo taun ngarep|Oculis Holding AG - Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep eyepointpharma.com|Prakiraan wutah bathi kanggo taun ngarep Kodiak Sciences Inc.|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Aldeyra Therapeutics Inc. (ALDX)|IRD - Prakiraan wutah bathi resik saben saham ing taun ngarep|Prakiraan wutah bathi kanggo taun ngarep OKYO (OKYO Pharma Limited)|ADVM - Prakiraan wutah bathi saben saham kanggo taun ngarep|OTLK: Prakiraan wutah bathi saben saham kanggo taun ngarep|CLSD (Clearside) - Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep|NBY: Prakiraan wutah bathi kanggo taun ngarep|Kiora Pharma (KPRX) - Prakiraan wutah bathi kanggo taun ngarep|ALIM (alimerasciences.com) - Prakiraan wutah bathi kanggo taun ngarep|eyenovia.com (EYEN) - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep GHSI|OCUP (Ocuphire) - Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi kanggo taun ngarep OPT (Opthea Ltd)